featured
Current Treatments for Pelvic Organ Prolapse
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
-
Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278-1283.
- American Urogynecologic Society (AUGS). Fundamentals for Female Pelvic Surgery. Washington, DC: American Urogynecologic Society. AUGS.org. http://www.augs.org/index.php?mo=cm&op=ld&fid=415. Accessed August 16, 2013.
-
Clark AL, Gregory T, Smith VJ, Edwards R. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2003;189(5):1261-1267.
- American Urological Association (AUA). Guideline for the Surgical Management of Female Stress Urinary Incontinence: Update (2009). Linthicum, MD: American Urological Association. auanet.org. http://www.auanet.org/education/guidelines/incontinence.cfm. Accessed August 16, 2013.
- U.S. Food and Drug Administration (FDA). FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence; 2008. Silver Spring, MD. U.S. Food and Drug Administration. Accessed August 16, 2013.
- U.S. Food and Drug Administration (FDA). FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse; 2011. Silver Spring, MD. U.S. Food and Drug Administration. fda.gov. Accessed August 16, 2013.
Disclosure statements are available on the authors' profiles: